The objective of adjunct anti-inflammatory therapy of bacterial meningitis is the containment of heightened inflammation caused by lysis of bacteria by antibiotics. This can be modelled by giving two consecutive intra-cisternal injections of lipopolysaccharide (LPS) to rabbits, the first at 0 h to induce inflammation to mimic that occurring during the proliferation of bacteria in the cerebrospinal fluid (CSF). and the second at 6 h to mimic inflammation subsequent to antibiotic-induced bacterial lysis. Injection of 2.5 ng of LPS induced pleocytosis at 4 h which was preceded by a peak of tumour necrosis factor (TNF) activity at 2 h. A subsequent injection of 25 ng of LPS at 6 h induced second peaks of pleocytosis and CSF TNF. Dexamethasone (1.5 mg/kg, i.v.) administered 15 min or 1 h before the second injection of LPS tended only to reduce CSF TNF, but effectively prohibited further pleocytosis. Brain TNFα mRNA levels were unchanged at 6 and 7 h after LPS injection, and were unaffected by dexamethasone. These results indicate that the subarachnoid space is distinct from the general circulation in that the TNF-producing cells present do not display a hypo-responsive state towards LPS as occurs when LPS is injected systemically. Furthermore, dexamethasone is able to attenuate the secondary inflammatory response resulting from a second LPS injection without eliminating a second peak of TNF activity.
ShariefM. K.,
CiardiM.,
ThompsonE. J. Blood-brain barrier damage in patients with bacterial meningitis: association with tumour necrosis factor-α but not interleukin-1ß. J Infect Dis1992; 166:350–358
ChavanetP.,
BonnotteB.,
GuiguetM. High concentrations of intrathecal interleukin-6 in human bacterial and non-bacterial meningitis. J Infect Dis1992; 166:428–431
MertsolaJ.,
KennedyW. A.,
WaagnerD. Endotoxin concentrations in cerebrospinal fluid correlate with clinical severity and neurologic outcome of Haemophilus influenzae type b meningitis. Am J Dis Child1991; 145:1099–1103
ArditiM.,
ManogueK. R.,
CaplanM.,
YogevR. Cerebrospinal fluid cachetin/tumor necrosis factor-a and platelet-activating factor concentrations and severity of bacterial meningitis in children. J Infect Dis1990; 162:139–147
MustafaM. M.,
LevelM. H.,
RamiloO. Correlation of interleukin-1ß and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J Pediatr1989; 115:208–213
MustafaM. M.,
RamiloO.,
Saez-LlorensX.,
OlsenK. D.,
MagnessR. R.,
McCrackenG. H. Cerebrospinal fluid prostaglandins, interleukin 1ß and tumor necrosis factor in bacterial meningitis. Clinical and laboratory correlations in placebo-treated and dexamethasone-treated patients. Am J Dis Child1990; 144:883–887
OdioC. M.,
FaingezichtI.,
ParisM. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med1991; 324:1525–1531
GirgisN. I.,
FaridZ.,
MikhailI. A.,
FarragI.,
SultanY.,
KilpatrickM. E. Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J1989; 8:848–851
LebelM. H.,
HoytJ.,
WaagnerD. C.,
RollinsN. K.,
FinitzoT.,
McCrackenG. H. Magnetic resonance imaging and dexa-methasone therapy for bacterial meningitis. Am J Dis Child1988; 143:301–306
LevelM. H.,
FreijB. J.,
SyrogiannopoulosG. A. Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo controlled trials. N Engl J Med1988; 319:964–971
McGowanJ. E.,
ChesneyP. J.,
CrossleyK. B.,
LaForceF. M. Guidelines for the use of systemic glucocorticosteroids in the management of selected infections. J Infect Dis1992; 165:1–13
American Academy of Pediatrics Committee on Infectious Diseases. Dexamethasone therapy for bacterial meningitis in infants and children. Pediatrics1990; 86:130–133
HavensP. L.,
WendelbergerK. J.,
HoffmanG. M.,
LeeM. B.,
ChusidM. J. Corticosteroids as adjunctive therapy in bacterial meningitis. A meta-analysis of clinical trials. Am J Dis Child1989; 143:1051–1055
DaceyR. G.,
SandeM. A. Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrob Agents Chemother1974; 6:437–441
SpectorR.,
LorenzoA. V. Inhibition of penicillin transport from the cerebrospinal fluid after intra-cisternal inoculation of bacteria. J Clin Invest1974; 54:316–325
TuomanenE.,
TomaszA.,
HengstlerB.,
ZakO. The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. J Infect Dis1985; 151:535–540
ItoH.,
YamamotoS.,
KurodaS. Molecular cloning and expression in Escherichia coli of the cDNA coding for rabbit tumor necrosis factor. DMA1986; 5:149–156
ZwicklM.,
ZaninettaD.,
McMasterG. K.,
HardmanN. Selective cloning of B cell hybridoma-specific rearranged immunoglobulin gene loci using the polymerase chain reaction. J Immunol Methods1990; 130:49–55
NielsonP. J.,
McMasterG. K.,
TrachselH. Cloning of eukaryotic protein synthesis initiation factor genes: isolation and characterization of cDNA clones encoding elF-4a. Nucleic Acids Res1985; 13:6867–6880
KadurugamuwaJ. L.,
HengstlerB.,
ZakO. Cerebrospinal fluid protein profile in experimental pneumococcal meningitis and its alteration by ampicillin and anti-inflammatory agents. J Infect Dis1989; 159:26–34
SyrogiannopoulosG. A.,
OlsenK. D.,
ReischJ. S. McCracken GH. Dexamethasone in the treatment of experimental Haemophilus influenzae tvpe b meningitis. J Infect Dis1987; 155:213–219
MustafaM. M.,
RamiloO.,
OlsenK. D. Tumor necrosis factor in mediating experimental Haemophilus influenzae type b meningitis. J Clin Invest1989; 84:1253–1259
WaageA.,
HalstensenA.,
ShalabyR.,
BrandtzaegP.,
KierulfP.,
EspevikT. Local production of tumor necrosis factor x. interleukin 1. and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J Exp Med1989; 170:1859–1867
KimK. S.,
WassC. A.,
CrossA. S.,
OpalS. M. Modulation of blood-brain barrier permeability by tumor necrosis factor and antibody to tumor necrosis factor in the rat. Lvmphokine Cvtokine Res1992; 11:293–298
VelascoS.,
TarlowM.,
OlsenK.,
ShayJ. W.,
McCrackenG. H.,
NisenP. D. Temperature-dependent modulation of lipo-polysaccharide-induced interleukin-If and tumor necrosis factor x expression in cultured human astroglial cells by dexamethasone and indomethacin. J Clin Invest1991; 87:1674–1680
ChungI. Y.,
BenvemsteE. N. Tumor necrosis factor-x production by astrocytes. Induction by lipopolysaccharide. IFN-γ and IL-1. ß J Immunol1990; 144:2999–3007
RobbinsD. S.,
ShiraziY.,
DrysdaleB. E.,
LiebermanA.,
ShinH. S.,
ShinM. L. Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J Immunol1987; 139:2593–2597
CybulskyM. I.,
McCombD. J.,
MovatH. Z. Neutrophil leukocyte emigration induced by endotoxin. Mediator roles of interleukin I and tumor necrosis factor a. J Immunol1988; 140:3144–3149
ShalabyM. R.,
PalladinoM. A.,
HirabayashiS. E. Receptor binding and activation of polymorphonuclear neutrophils bv tumor necrosis factor-alpha. J Leukoc Biol1987; 41:196–204
SaukkonenK.,
SandeS.,
CioffeC. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J Exp Med1990; 171:439–448
QuagiiarelloV. J.,
WispelweyB.,
LongW. J.,
ScheldW. M. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J Clin Invest1991; 87:1360–1366
MustafaM. M.,
RamiloO.,
MertsolaJ. Modulation of inflammation and cachectin activity in relation to treatment of experimental Haemophilus influenzae type b meningitis. J Infect Dis1989; 160:818–825
UlichT. R.,
GuoK. Z.,
IrwinB.,
RemickD. G.,
DavatelisG. N. Endotoxin-induced cytokine gene expression in vivo. 2. Regulation of tumor necrosis factor and interleukin-1 α\β expression and suppression. Am J Pathol1990; 137:1173–1185
RemickD. G.,
StricterR. M.,
LynchJ. P.,
NguyenD.,
EskandariM.,
KunkelS. L. In vivo dynamics of murine tumor necrosis factor-x gene expression. Kinetics of dexamethasone-induced suppression. Lab Invest1989; 60:766–771
BeutlerB.,
KrochinN.,
MilsarkI. W.,
LuedkeC.,
CeramiA. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science1986; 232:977–980
HanJ.,
ThompsonP.,
BeutlerB. Dexamethasone and pentoxi-fylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med1990; 172:391–394
Guerra-RomeroL.,
TauberM. G.,
FournierM. A.,
TureenJ. H. Lactate and glucose concentrations in brain interstitial fluid, cerebrospinal fluid, and serum during experimental pneumococcal meningitis. J Infect Dis1992; 166:546–550